GRAIL, Inc.(GRAL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GRAL GRAIL, Inc.

Market Closed 04-24 16:00:00 EDT

54.42

+3.77

+7.44%

盘后54.60

+0.18+0.33%

19:53 EDT

High54.98	Low50.05	Vol590.72K
Open50.99	D1 Closing50.65	Amplitude9.73%
Mkt Cap2.23B	Tradable Cap1.86B	Total Shares41.02M
T/O31.65M	T/O Rate1.73%	Tradable Shares34.19M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"GRAL","market":"US","secType":"STK","nameCN":"GRAIL, Inc.","latestPrice":54.42,"timestamp":1777060800000,"preClose":50.65,"halted":0,"volume":590717,"hourTrading":{"tag":"盘后","latestPrice":54.6,"preClose":54.42,"latestTime":"19:53 EDT","volume":11588,"amount":630730.7709,"timestamp":1777074823244,"change":0.18,"changeRate":0.003308,"amplitude":0.003308},"delay":0,"changeRate":0.07443237907206324,"floatShares":34193700,"shares":41020255,"eps":-11.110457,"marketStatus":"Market Closed","change":3.77,"latestTime":"04-24 16:00:00 EDT","open":50.99,"high":54.98,"low":50.05,"amount":31647836.945798,"amplitude":0.097335,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-11.110457,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1777276800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":50.65,"preHourTrading":{"tag":"盘前","latestPrice":51.05,"preClose":50.65,"latestTime":"08:57 EDT","volume":185,"amount":9406.00125,"timestamp":1777035476939,"change":0.4,"changeRate":0.007897,"amplitude":0.024877},"postHourTrading":{"tag":"盘后","latestPrice":54.6,"preClose":54.42,"latestTime":"19:53 EDT","volume":11588,"amount":630730.7709,"timestamp":1777074823244,"change":0.18,"changeRate":0.003308,"amplitude":0.003308},"volumeRatio":1.137500293286837,"impliedVol":1.0201,"impliedVolPercentile":0.7251},"requestUrl":"/m/hq/s/GRAL","defaultTab":"news","newsList":[{"id":"2629027985","title":"Grail schedules first-quarter financial results webcast and conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2629027985","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629027985?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:01","pubTimestamp":1776888094,"startTime":"0","endTime":"0","summary":"Grail will release first-quarter 2026 financial results on May 5, 2026, following market close.Management will host webcast plus conference call on May 5, 2026 at 1:30 p.m. PT / 4:30 p.m. ET.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL7yNWvV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629068035","title":"Grail to present late-breaking NHS-Galleri trial results at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2629068035","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629068035?lang=en_us&edition=fundamental","pubTime":"2026-04-22 04:54","pubTimestamp":1776804863,"startTime":"0","endTime":"0","summary":"Grail set late-breaking oral presentations at 2026 ASCO Annual Meeting in Chicago, May 29-June 2, 2026, for new data from NHS-Galleri trial and final results from PATHFINDER 2.NHS-Galleri results will be presented in the future, expanding on topline findings announced in February 2026 that indicated earlier-stage detection and fewer late-stage cancer diagnoses with Galleri added to standard screening.PATHFINDER 2 complete dataset will be presented in the future, building on results previously presented in October 2025 that showed Galleri increased cancer detection when used alongside guideline-recommended screenings.Grail highlighted enrollment of more than 174,000 participants across both studies, positioning the evidence package to support broader adoption of its Galleri multi-cancer early detection blood test.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL5nsmXv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626865191","title":"Grail Inc : Mizuho Initiates Coverage With Neutral Rating; Target Price $58","url":"https://stock-news.laohu8.com/highlight/detail?id=2626865191","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626865191?lang=en_us&edition=fundamental","pubTime":"2026-04-10 18:38","pubTimestamp":1775817520,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nFWN40T0E5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626319638","title":"Grail Initiated at Neutral by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2626319638","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626319638?lang=en_us&edition=fundamental","pubTime":"2026-04-10 17:48","pubTimestamp":1775814480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GRAL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 10, 2026 05:48 ET (09:48 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626933971","title":"Grail initiated with a Neutral at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2626933971","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626933971?lang=en_us&edition=fundamental","pubTime":"2026-04-10 16:45","pubTimestamp":1775810711,"startTime":"0","endTime":"0","summary":"Piper Sandler initiated coverage of Grail (GRAL) with a Neutral rating and $54 price target The company holds the largest clinical datasets of any ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-initiated-with-a-neutral-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-initiated-with-a-neutral-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626678961","title":"U.S. RESEARCH ROUNDUP-Chevron, Littelfuse, Parker-Hannifin","url":"https://stock-news.laohu8.com/highlight/detail?id=2626678961","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626678961?lang=en_us&edition=fundamental","pubTime":"2026-04-10 15:38","pubTimestamp":1775806689,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Chevron, Littelfuse, Parker-HannifinApril 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies on Friday, inclu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nL4N40T0L1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV","AMPL","DFTX","GRAL","CCC","LITX","CVX","AMP","ADSK","FNF","BRBR","COHR","CLF","LU2125154778.USD","LU2211815571.USD","LFUS","CBZ","LINT","ALAB","CE","LITE","NAKA","IE00BGHQF748.EUR","ADBG","CC","AIM","DE","ASRT","ESAB","ADBE","CL","INTC","FRPT","CAI","BK4592","GWRE","INFQ","STZ","DOCU","LABX","DAR","ELVN","LSCC","HRI","DOW","COHX","IE00B2B36J28.USD","INTW","ITW","HUBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625656939","title":"Grail partners with Epic to integrate Galleri cancer test into EHR platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2625656939","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625656939?lang=en_us&edition=fundamental","pubTime":"2026-04-08 04:01","pubTimestamp":1775592115,"startTime":"0","endTime":"0","summary":"Grail entered collaboration with Epic to integrate Galleri multi-cancer early detection test into Epic electronic health record platform.Integration via Epic Aura targets access for about 450 health systems through existing Epic patient portals.Clinicians will be able to order Galleri at point of care within native Epic workflows, with results delivery and follow-up management inside Epic.Implementation planning started in Q1 2026 through initial integrations and early adopter programs.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDL5Zwtxx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624436565","title":"BRIEF-Superpower Announces Strategic Partnership With GRAIL For Multi-Cancer Early Detection Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2624436565","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624436565?lang=en_us&edition=fundamental","pubTime":"2026-04-02 01:28","pubTimestamp":1775064525,"startTime":"0","endTime":"0","summary":"BRIEF-Superpower Announces Strategic Partnership With GRAIL For Multi-Cancer Early Detection TestApril 1 (Reuters) - Superpower:SUPERPOWER: STRATEGIC PARTNERSHIP WITH GRAIL FOR MULTI-CANCER EARLY DETE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nFWN40K1BL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624548707","title":"Superpower: Strategic Partnership With Grail for Multi-Cancer Early Detection Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2624548707","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624548707?lang=en_us&edition=fundamental","pubTime":"2026-04-02 01:10","pubTimestamp":1775063436,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nFWN40K1BL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624548083","title":"Superpower partners with Grail to offer Galleri cancer blood test to members","url":"https://stock-news.laohu8.com/highlight/detail?id=2624548083","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624548083?lang=en_us&edition=fundamental","pubTime":"2026-04-02 01:10","pubTimestamp":1775063428,"startTime":"0","endTime":"0","summary":"Grail entered strategic partnership with Superpower to expand access to Galleri multi-cancer early detection blood test through Superpower platform.Superpower members will be able to add Galleri, which screens for cancer signals linked to more than 50 cancer types.PATHFINDER 2 study data showed adding Galleri to standard screenings increased cancer detection more than seven-fold.Offering targets adults at elevated cancer risk, including those aged 50 or older.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL8VgBWr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623442643","title":"Grail Is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2623442643","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623442643?lang=en_us&edition=fundamental","pubTime":"2026-03-30 23:35","pubTimestamp":1774884900,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GRAL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 30, 2026 11:35 ET (15:35 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623312097","title":"Grail price target lowered to $75 from $130 at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2623312097","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623312097?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:54","pubTimestamp":1774871676,"startTime":"0","endTime":"0","summary":"Guggenheim lowered the firm’s price target on Grail (GRAL) to $75 from $130 and keeps a Buy rating on the shares. The firm adjusted models and fore...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-price-target-lowered-to-75-from-130-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-price-target-lowered-to-75-from-130-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621702682","title":"GRAIL (GRAL) Valuation Check As CEO Transition And New Stock Shelf Shape Market Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=2621702682","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621702682?lang=en_us&edition=fundamental","pubTime":"2026-03-23 21:07","pubTimestamp":1774271221,"startTime":"0","endTime":"0","summary":"GRAIL (GRAL) is back in focus after announcing that CEO Bob Ragusa will retire in June 2026. President Josh Ofman will take over as CEO and Board member, and a new common stock shelf registration was filed.\nSee our latest analysis for GRAIL.\nThe leadership transition and new stock shelf arrive after a sharp 48.75% 90 day share price decline and a 47.29% negative year to date share price return. However, the 1 year total shareholder return of 45.78% indicates that longer term momentum has...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/grail-gral-valuation-check-as-ceo-transition-and-new-stock-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/grail-gral-valuation-check-as-ceo-transition-and-new-stock-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620023163","title":"BUZZ-Grail rises after TD Cowen upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2620023163","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620023163?lang=en_us&edition=fundamental","pubTime":"2026-03-18 17:51","pubTimestamp":1773827497,"startTime":"0","endTime":"0","summary":"BUZZ-Grail rises after TD Cowen upgrade** Shares of diagnostics firm Grail GRAL.O rise 4.2% to $49.36 premarket** Brokerage TD Cowen upgrades GRAIL to “buy” from “hold”, but cuts its price target to $65 from $114** TD Cowen says the recent sell-off after the NHS Galleri trial miss has created an attractive entry point, despite the study missing its main goal** Brokerage says its expert checks remain positive on GRAIL’s blood test that aims to detect multiple cancers early, with a meaningful drop in late-stage cancers** TD Cowen estimates a roughly 75% chance of U.S. approval for the test and around a 50% chance of Medicare coverage** GRAIL shares had fallen about 60% since mid-February before the upgrade, brokerage says ** Shares rose nearly four fold in 2025  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nL4N4060QL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620623163","title":"Grail Shares up 3.7% Premarket After TD Cowen Raises to Buy From Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2620623163","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620623163?lang=en_us&edition=fundamental","pubTime":"2026-03-18 17:50","pubTimestamp":1773827406,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nL4N4060QZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620265231","title":"Analysts’ Top Healthcare Picks: GRAIL Inc (GRAL), Bicycle Therapeutics (BCYC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620265231","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620265231?lang=en_us&edition=fundamental","pubTime":"2026-03-18 17:50","pubTimestamp":1773827405,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on GRAIL Inc (GRAL – Research Report) and Bicycle Thera...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-grail-inc-gral-bicycle-therapeutics-bcyc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-grail-inc-gral-bicycle-therapeutics-bcyc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GRAL","LU0029874061.USD","BK4581","BK4137","LABU","BK4585","BCYC","XBI","BK4139","LU0128526141.USD","HCSG","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620392632","title":"Grail Inc : TD Cowen Raises to Buy From Hold; Cuts Target Price to $65 From $114","url":"https://stock-news.laohu8.com/highlight/detail?id=2620392632","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620392632?lang=en_us&edition=fundamental","pubTime":"2026-03-18 17:37","pubTimestamp":1773826667,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nFWN4060N0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620414159","title":"Does GRAIL (GRAL) Elevating Josh Ofman to CEO Reframe Its Management Quality Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2620414159","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620414159?lang=en_us&edition=fundamental","pubTime":"2026-03-17 09:23","pubTimestamp":1773710603,"startTime":"0","endTime":"0","summary":"In March 2026, GRAIL, Inc. announced that CEO Bob Ragusa will retire on June 1, 2026, with President Josh Ofman, MD, MSHS, set to become CEO and join the Board, while Ragusa remains as a senior advisor through March 2027.\nThis leadership transition places a long-time internal executive with deep clinical and health policy experience at the center of GRAIL’s next phase of development.\nNext, we’ll examine how Ofman’s planned move from president to CEO could reshape GRAIL’s investment narrative...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/does-grail-gral-elevating-josh-ofman-to-ceo-reframe-its-mana","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/does-grail-gral-elevating-josh-ofman-to-ceo-reframe-its-mana","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619194509","title":"Guggenheim Sticks to Their Buy Rating for GRAIL Inc (GRAL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2619194509","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619194509?lang=en_us&edition=fundamental","pubTime":"2026-03-13 19:58","pubTimestamp":1773403094,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Subbu Nambi from Guggenheim maintained a Buy rating on GRAIL Inc, with a price target of $130.00. The company’s sha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-their-buy-rating-for-grail-inc-gral-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-their-buy-rating-for-grail-inc-gral-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619547194","title":"Canaccord Genuity Reaffirms Their Buy Rating on GRAIL Inc (GRAL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2619547194","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619547194?lang=en_us&edition=fundamental","pubTime":"2026-03-13 19:57","pubTimestamp":1773403050,"startTime":"0","endTime":"0","summary":"In a report released today, Kyle Mikson CFA from Canaccord Genuity reiterated a Buy rating on GRAIL Inc, with a price target of $80.00. Mikson CFA ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-reaffirms-their-buy-rating-on-grail-inc-gral-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-reaffirms-their-buy-rating-on-grail-inc-gral-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GRAL"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://grail.com;investors.grail.com","stockEarnings":[{"period":"1week","weight":0.0524},{"period":"1month","weight":0.0407},{"period":"3month","weight":-0.4812},{"period":"6month","weight":-0.3912},{"period":"1year","weight":0.4439},{"period":"ytd","weight":-0.3642}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.087},{"period":"3month","weight":0.0359},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3059},{"period":"ytd","weight":0.047}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"GRAIL, Inc.","nameEN":"GRAIL, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GRAIL, Inc.(GRAL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GRAIL, Inc.(GRAL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GRAIL, Inc.,GRAL,GRAIL, Inc.股票,GRAIL, Inc.股票老虎,GRAIL, Inc.股票老虎国际,GRAIL, Inc.行情,GRAIL, Inc.股票行情,GRAIL, Inc.股价,GRAIL, Inc.股市,GRAIL, Inc.股票价格,GRAIL, Inc.股票交易,GRAIL, Inc.股票购买,GRAIL, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GRAIL, Inc.(GRAL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GRAIL, Inc.(GRAL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}